Literature DB >> 24337657

De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis.

Willa Thorson1, Oscar Diaz-Horta, Joseph Foster, Michail Spiliopoulos, Rubén Quintero, Amjad Farooq, Susan Blanton, Mustafa Tekin.   

Abstract

Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) is characterized by prenatal-onset distended urinary bladder with functional intestinal obstruction, requiring extensive surgical intervention for survival. While it is believed to be an autosomal recessive disorder, most cases are sporadic. Through whole-exome sequencing in a child with MMIHS, we identified a de novo mutation, p.R178L, in the gene encoding the smooth muscle gamma-2 actin, ACTG2. We subsequently detected another de novo ACTG2 mutation, p.R178C, in an additional child with MMIHS. Actg2 transcripts were primarily found in murine urinary bladder and intestinal tissues. Structural analysis and functional experiments suggested that both ACTG2 mutants interfere with proper polymerization of ACTG2 into thin filaments, leading to impaired contractility of the smooth muscle. In conclusion, our study suggests a pathogenic mechanism for MMIHS by identifying causative ACTG2 mutations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337657     DOI: 10.1007/s00439-013-1406-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

Review 1.  Abnormalities of the fetal bladder.

Authors:  Jenny Yiee; Duncan Wilcox
Journal:  Semin Fetal Neonatal Med       Date:  2007-11-28       Impact factor: 3.926

2.  The crystal structure of uncomplexed actin in the ADP state.

Authors:  L R Otterbein; P Graceffa; R Dominguez
Journal:  Science       Date:  2001-07-27       Impact factor: 47.728

3.  Megacystis-microcolon-intestinal hypoperistalsis syndrome: a new cause of intestinal obstruction in the newborn. Report of radiologic findings in five newborn girls.

Authors:  W E Berdon; D H Baker; W A Blanc; B Gay; T V Santulli; C Donovan
Journal:  AJR Am J Roentgenol       Date:  1976-05       Impact factor: 3.959

Review 4.  Familial megacystis microcolon intestinal hypoperistalsis syndrome: a systematic review.

Authors:  Danielle Mc Laughlin; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

Review 5.  Actin structure and function.

Authors:  Roberto Dominguez; Kenneth C Holmes
Journal:  Annu Rev Biophys       Date:  2011       Impact factor: 12.981

6.  Megacystis microcolon intestinal hypoperistalsis syndrome: evidence of a primary myocellular defect of contractile fiber synthesis.

Authors:  A O Ciftci; R C Cook; D van Velzen
Journal:  J Pediatr Surg       Date:  1996-12       Impact factor: 2.545

7.  ACTA2 mutation with childhood cardiovascular, autonomic and brain anomalies and severe outcome.

Authors:  Marije E C Meuwissen; Maarten H Lequin; Karen Bindels-de Heus; Hennie T Bruggenwirth; Maarten F C M Knapen; Michiel Dalinghaus; René de Coo; Yolande van Bever; Beerend H J Winkelman; Grazia M S Mancini
Journal:  Am J Med Genet A       Date:  2013-04-23       Impact factor: 2.802

8.  Alterations in smooth muscle contractile and cytoskeleton proteins and interstitial cells of Cajal in megacystis microcolon intestinal hypoperistalsis syndrome.

Authors:  A Piaseczna Piotrowska; U Rolle; B Chertin; D De Caluwé; A Bianchi; P Puri
Journal:  J Pediatr Surg       Date:  2003-05       Impact factor: 2.545

9.  Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.

Authors:  Heli J Lehtonen; Taina Sipponen; Sari Tojkander; Riitta Karikoski; Heikki Järvinen; Nigel G Laing; Pekka Lappalainen; Lauri A Aaltonen; Sari Tuupanen
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

10.  A versatile viral system for expression and depletion of proteins in mammalian cells.

Authors:  Eric Campeau; Victoria E Ruhl; Francis Rodier; Corey L Smith; Brittany L Rahmberg; Jill O Fuss; Judith Campisi; Paul Yaswen; Priscilla K Cooper; Paul D Kaufman
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more
  35 in total

1.  Diagnosis of Chronic Intestinal Pseudo-obstruction and Megacystis by Sequencing the ACTG2 Gene.

Authors:  Aubrey Milunsky; Clinton Baldwin; Xiaoying Zhang; Daniel Primack; Adrian Curnow; Jeff Milunsky
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-10       Impact factor: 2.839

2.  Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution.

Authors:  Joakim Klar; Doroteya Raykova; Elisabet Gustafson; Iveta Tóthová; Adam Ameur; Alkwin Wanders; Niklas Dahl
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 3.  Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.

Authors:  Carolina Araujo Moreno; Konradin Metze; Elizete Aparecida Lomazi; Débora Romeo Bertola; Ricardo Henrique Almeida Barbosa; Viviana Cosentino; Nara Sobreira; Denise Pontes Cavalcanti
Journal:  Am J Med Genet A       Date:  2016-08-02       Impact factor: 2.802

Review 4.  Chronic Intestinal Pseudo-obstruction.

Authors:  Khalil El-Chammas; Manu R Sood
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

5.  Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.

Authors:  Nurit Assia Batzir; Pranjali Kishor Bhagwat; Austin Larson; Zeynep Coban Akdemir; Maciej Bagłaj; Leon Bofferding; Katherine B Bosanko; Skander Bouassida; Bert Callewaert; Ashley Cannon; Yazmin Enchautegui Colon; Adolfo D Garnica; Margaret H Harr; Sandra Heck; Anna C E Hurst; Shalini N Jhangiani; Bertrand Isidor; Rebecca O Littlejohn; Pengfei Liu; Pilar Magoulas; Helen Mar Fan; Ronit Marom; Scott McLean; Marjan M Nezarati; Kimberly M Nugent; Michael B Petersen; Maria L Rocha; Elizabeth Roeder; Robert Smigiel; Ian Tully; James Weisfeld-Adams; Katerina O Wells; Jennifer E Posey; James R Lupski; Arthur L Beaudet; Michael F Wangler
Journal:  Hum Mutat       Date:  2019-12-19       Impact factor: 4.878

6.  Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice.

Authors:  Danny Halim; Michael P Wilson; Daniel Oliver; Erwin Brosens; Joke B G M Verheij; Yu Han; Vivek Nanda; Qing Lyu; Michael Doukas; Hans Stoop; Rutger W W Brouwer; Wilfred F J van IJcken; Orazio J Slivano; Alan J Burns; Christine K Christie; Karen L de Mesy Bentley; Alice S Brooks; Dick Tibboel; Suowen Xu; Zheng Gen Jin; Tono Djuwantono; Wei Yan; Maria M Alves; Robert M W Hofstra; Joseph M Miano
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

7.  Loss-of-Function Variants in MYLK Cause Recessive Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.

Authors:  Danny Halim; Erwin Brosens; Françoise Muller; Michael F Wangler; Arthur L Beaudet; James R Lupski; Zeynep H Coban Akdemir; Michael Doukas; Hans J Stoop; Bianca M de Graaf; Rutger W W Brouwer; Wilfred F J van Ijcken; Jean-François Oury; Jonathan Rosenblatt; Alan J Burns; Dick Tibboel; Robert M W Hofstra; Maria M Alves
Journal:  Am J Hum Genet       Date:  2017-06-08       Impact factor: 11.025

8.  Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.

Authors:  Katherine Gurdziel; Kyle R Vogt; Katherine D Walton; Gary K Schneider; Deborah L Gumucio
Journal:  Dev Dyn       Date:  2016-03-17       Impact factor: 3.780

9.  Homozygous deletion in MYL9 expands the molecular basis of megacystis-microcolon-intestinal hypoperistalsis syndrome.

Authors:  Carolina Araujo Moreno; Nara Sobreira; Elizabeth Pugh; Peng Zhang; Gary Steel; Fábio Rossi Torres; Denise Pontes Cavalcanti
Journal:  Eur J Hum Genet       Date:  2018-02-16       Impact factor: 4.246

10.  Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.

Authors:  Ivana Matera; Marta Rusmini; Yiran Guo; Margherita Lerone; Jiankang Li; Jianguo Zhang; Marco Di Duca; Paolo Nozza; Manuela Mosconi; Alessio Pini Prato; Giuseppe Martucciello; Arrigo Barabino; Francesco Morandi; Roberto De Giorgio; Vincenzo Stanghellini; Roberto Ravazzolo; Marcella Devoto; Hakon Hakonarson; Isabella Ceccherini
Journal:  Eur J Hum Genet       Date:  2016-01-27       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.